Mrs Ambar E Diaz Del Valle, MS | |
Calle Dufresne #19 Suite 1, Humacao, PR 00791 | |
(787) 341-8626 | |
Not Available |
Full Name | Mrs Ambar E Diaz Del Valle |
---|---|
Gender | Female |
Speciality | Psychologist |
Location | Calle Dufresne #19 Suite 1, Humacao, Puerto Rico |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1710145651 | NPI | - | NPPES |
00018214 | Medicaid | MS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | (* (Not Available)) | Secondary |
103T00000X | Psychologist | 5362 (Puerto Rico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Ambar E Diaz Del Valle, MS Po Box 763, Yabucoa, PR 00767-0763 Ph: (787) 341-8626 | Mrs Ambar E Diaz Del Valle, MS Calle Dufresne #19 Suite 1, Humacao, PR 00791 Ph: (787) 341-8626 |
News Archive
Dr. Steven A. Wartman, president and CEO of the Association of Academic Health Centers (AAHC), urged Senate Majority Leader Harry Reid to ensure that health reform create an integrated, coordinated national health workforce policy by incorporating four AAHC recommendations into Senate health reform legislation.
Researchers hope to one day use stem cells to heal burns, patch damaged heart tissue, even grow kidneys and other transplantable organs from scratch.
The Miami Herald/The Sun Sentinel: "The Florida Department of Health plans to drop about 350 uninsured HIV/AIDS patients from a federally funded program that pays for all or most of their drugs, because of a budget crisis. An additional 2,000 or more HIV-positive patients are at risk of being bumped from the program unless the state can close a $16 million shortfall in the next few months, officials said Tuesday.
EvaluatePharma, the premier provider of pharmaceutical and biotech analysis including consensus forecasts, today released its World Preview 2018 report, providing an in-depth look at how the patent cliff will reshape the drug industry over the next six years — with valuable insight into which companies and products will come out as winners.
More than a dozen organizations are asking that Dr. Margaret Hamburg, who has headed the Food and Drug Administration since 2009, be replaced because under her leadership they say the agency's policies have contributed to prescription painkiller abuse.
› Verified 8 days ago